Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes
Interferon-alpha (IFN-α) is suggested to cause pharmacokinetic drug interactions by lowering expression of drug disposition genes through affecting the activities of nuclear factor kappa B (NF-ĸB) and pregnane X receptor (PXR). The time-resolved impact of IFN-α 2a (1000 U/mL; 5000 U/mL; 2 h to 30 h)...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
28 May 2021
|
| In: |
Pharmaceutics
Year: 2021, Jahrgang: 13, Heft: 6, Pages: 1-11 |
| ISSN: | 1999-4923 |
| DOI: | 10.3390/pharmaceutics13060808 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/pharmaceutics13060808 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1999-4923/13/6/808 
|
| Verfasserangaben: | Dirk Theile, Lelia Wagner, Cindy Bay, Walter Emil Haefeli and Johanna Weiss |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1762885336 | ||
| 003 | DE-627 | ||
| 005 | 20220820015728.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 210714s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/pharmaceutics13060808 |2 doi | |
| 035 | |a (DE-627)1762885336 | ||
| 035 | |a (DE-599)KXP1762885336 | ||
| 035 | |a (OCoLC)1341418378 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Theile, Dirk |e VerfasserIn |0 (DE-588)1019114428 |0 (DE-627)684195658 |0 (DE-576)356996360 |4 aut | |
| 245 | 1 | 0 | |a Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes |c Dirk Theile, Lelia Wagner, Cindy Bay, Walter Emil Haefeli and Johanna Weiss |
| 264 | 1 | |c 28 May 2021 | |
| 300 | |a 11 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 14.07.2021 | ||
| 520 | |a Interferon-alpha (IFN-α) is suggested to cause pharmacokinetic drug interactions by lowering expression of drug disposition genes through affecting the activities of nuclear factor kappa B (NF-ĸB) and pregnane X receptor (PXR). The time-resolved impact of IFN-α 2a (1000 U/mL; 5000 U/mL; 2 h to 30 h) on the activities of NF-ĸB and PXR and mRNA expression (5000 U/mL; 24 h, 48 h) of selected drug disposition genes and on cytochrome P450 (CYP3A4) activity in LS180 cells (5000 U/mL; 24 h, 48 h) was evaluated using luciferase-based reporter gene assays, reverse transcription polymerase chain reaction, and luminescence-based CYP3A4 activity assays. The cross-talk between NF-ĸB activation and PXR suppression was evaluated by NF-ĸB blockage (10 µM parthenolide). IFN-α 2a initially (2 h, 6 h) enhanced NF-ĸB activity 2-fold and suppressed PXR activity by 30%. mRNA of CYP3A4 was halved, whereas UGT1A1 was increased (1.35-fold) after 24 h. After 48 h, ABCB1 expression was increased (1.76-fold). CYP3A4 activity remained unchanged after 24 h, but was enhanced after 48 h (1.35-fold). IFN-α 2a demonstrated short-term suppressive effects on PXR activity and CYP3A4 mRNA expression, likely mediated by activated NF-ĸB. Longer exposure enhanced CYP3A4 activity. Clinical trials should evaluate the relevance by investigating the temporal effects of IFN-α on CYP3A4 using a sensitive marker substrate. | ||
| 650 | 4 | |a cytochrome P-450 3A4 | |
| 650 | 4 | |a interferon-alpha | |
| 650 | 4 | |a nuclear factor kappa B | |
| 650 | 4 | |a pharmacokinetic drug-drug interactions | |
| 650 | 4 | |a pregnane X receptor | |
| 700 | 1 | |a Wagner, Lelia |d 1994- |e VerfasserIn |0 (DE-588)1230491139 |0 (DE-627)1752949730 |4 aut | |
| 700 | 1 | |a Bay, Cindy |e VerfasserIn |4 aut | |
| 700 | 1 | |a Haefeli, Walter E. |d 1958- |e VerfasserIn |0 (DE-588)124572359 |0 (DE-627)656806141 |0 (DE-576)340514221 |4 aut | |
| 700 | 1 | |a Weiß, Johanna |e VerfasserIn |0 (DE-588)1050230906 |0 (DE-627)783666322 |0 (DE-576)404441114 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Pharmaceutics |d Basel : MDPI, 2009 |g 13(2021), 6, Artikel-ID 808, Seite 1-11 |h Online-Ressource |w (DE-627)614096529 |w (DE-600)2527217-2 |w (DE-576)313958653 |x 1999-4923 |7 nnas |a Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes |
| 773 | 1 | 8 | |g volume:13 |g year:2021 |g number:6 |g elocationid:808 |g pages:1-11 |g extent:11 |a Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes |
| 856 | 4 | 0 | |u https://doi.org/10.3390/pharmaceutics13060808 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/1999-4923/13/6/808 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20210714 | ||
| 993 | |a Article | ||
| 994 | |a 2021 | ||
| 998 | |g 1050230906 |a Weiß, Johanna |m 1050230906:Weiß, Johanna |d 910000 |d 910100 |e 910000PW1050230906 |e 910100PW1050230906 |k 0/910000/ |k 1/910000/910100/ |p 5 |y j | ||
| 998 | |g 124572359 |a Haefeli, Walter E. |m 124572359:Haefeli, Walter E. |d 910000 |d 910100 |e 910000PH124572359 |e 910100PH124572359 |k 0/910000/ |k 1/910000/910100/ |p 4 | ||
| 998 | |g 1230491139 |a Wagner, Lelia |m 1230491139:Wagner, Lelia |d 160000 |d 160100 |e 160000PW1230491139 |e 160100PW1230491139 |k 0/160000/ |k 1/160000/160100/ |p 2 | ||
| 998 | |g 1019114428 |a Theile, Dirk |m 1019114428:Theile, Dirk |d 910000 |d 910100 |d 50000 |e 910000PT1019114428 |e 910100PT1019114428 |e 50000PT1019114428 |k 0/910000/ |k 1/910000/910100/ |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1762885336 |e 3951135093 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1762885336"],"doi":["10.3390/pharmaceutics13060808"]},"physDesc":[{"extent":"11 S."}],"title":[{"title":"Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes","title_sort":"Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genes"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"origin":[{"dateIssuedDisp":"28 May 2021","dateIssuedKey":"2021"}],"relHost":[{"language":["eng"],"part":{"text":"13(2021), 6, Artikel-ID 808, Seite 1-11","pages":"1-11","extent":"11","issue":"6","year":"2021","volume":"13"},"pubHistory":["1.2009 -"],"note":["Gesehen am 28.05.14"],"disp":"Time-resolved effect of interferon-alpha 2a on activities of nuclear factor kappa B, pregnane X receptor and on drug disposition genesPharmaceutics","type":{"bibl":"periodical","media":"Online-Ressource"},"name":{"displayForm":["Molecular Diversity Preservation International"]},"recId":"614096529","title":[{"title_sort":"Pharmaceutics","title":"Pharmaceutics"}],"id":{"eki":["614096529"],"issn":["1999-4923"],"zdb":["2527217-2"]},"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"dateIssuedKey":"2009","publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-"}]}],"language":["eng"],"name":{"displayForm":["Dirk Theile, Lelia Wagner, Cindy Bay, Walter Emil Haefeli and Johanna Weiss"]},"note":["Gesehen am 14.07.2021"],"person":[{"display":"Theile, Dirk","given":"Dirk","role":"aut","family":"Theile"},{"display":"Wagner, Lelia","given":"Lelia","family":"Wagner","role":"aut"},{"given":"Cindy","display":"Bay, Cindy","role":"aut","family":"Bay"},{"given":"Walter E.","display":"Haefeli, Walter E.","role":"aut","family":"Haefeli"},{"given":"Johanna","display":"Weiß, Johanna","family":"Weiß","role":"aut"}],"recId":"1762885336"} | ||
| SRT | |a THEILEDIRKTIMERESOLV2820 | ||